In Pharma/Biotech Co-Promotion Agreements, Specificity Is The Best Policy
This article was originally published in The Pink Sheet Daily
Allergan, Genentech execs recommend clear definitions of roles and responsibility at the outset of deals between pharma and biotech.
You may also be interested in...
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13
Merger will create the leading generic injectable pharmaceutical company in the world.
Takeda sleep aid’s new Rx share has grown more than 50% since campaign began.